Liu et al. indicated that the radiolabeled CD133 targeted tracer (99mTc-SHNH-AC133) showed high tumor uptake (8.82 ± 0.73%ID/g) and high tumor-to-muscle ratios (13.18 ± 2.84) at 36 h. Here, PROM1 is linked to neoplasm.